Joshua T. Brumm, See Remarks at Dyne Therapeutics, Inc. (DYN), sold 24,064 shares at $9.41 ($226K) on 2023-09-18, disclosed to the SEC on 2023-09-20.
Seasonal sale ($226k) by See Remarks — this insider has traded DYN in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.41 | 12,032 | $113K | 50.0% |
| 2 | $9.41 | 12,032 | $113K | 50.0% |
| Total | $9.41 avg | 24,064 | $226K | 100% |
| Filing → |
| DYN | SELL | 2024-03-12 | $22.2M | — | Filing → |
| DYN | SELL | 2024-03-11 | $470K | — | Filing → |
| DYN | SELL | 2024-03-01 | $5.1M | — | Filing → |